维普期刊资源整合服务平台（V6.5）

92篇 您的检索式：作者名="BONNETERRE J"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Chemotherapy induced emesis: pathophysiology and prevention显示文摘	Mailliez A Bonneterre J	2010	Bull Cancer2010，97，2：	1
2	Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase Ⅰ study显示文摘	Bonneterre J Campone M Koralewski P	2007	Cancer Chemotherapy and Pharmacology2007，60，3：	1
3	ERbB2 oncogene in human breast cancer and its clinical significance 显示文摘	Revillion F Bonneterre J Peyrat JP	1998	Eur J Cancer1998，34，6：	1
4	Docetaxel vs 5 - Flnorouraeil plus vinorelbine in metastatic breast cancer after an thraeyeline therapy failure 显示文摘	BONNETERRE J ROCHE H MONNIER A	2002	Br J Cancer2002，87，11：	1
5	Urinary excretion of deoxypyndinolme in patients with breast cancer显示文摘	Nguyen-Pamart M Bonneterre J Hecxlud B	1995	Anticancer Res1995，15，：	1
6	Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial 显示文摘	Kerbrat P Roch6 H Bonneterre J	2007	Br J Cancer2007，96，11：	1
7	Phase Ⅱ multicent rerandomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer显示文摘	BONNETERRE J DIERAS V TUBIANA H M	2004	Br J Cancer2004，91，8：	1
8	ERBB2 oncogene in human breast cancer and its clinical significance显示文摘	Revillion F Bonneterre J P	1998	Eur J Cancer1998，34，：	1
9	Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial 显示文摘	Fargeot P Bonneterre J Roche H	2004	J Clin Oncol2004，22，23：	1
10	Vinorelbine in breast cancer显示文摘	Bonneterre J Penel N	2008	Expert Opin Pharmaeother2008，9，16：	1
11	Phase Ⅱ mul- ticentre randomised study of docetaxel plus epirubicin vs 5-flu- orouracil plus epimbicin and cyclophosphamide in metastatiC breast cancer 显示文摘	Bonneterre J Dieras V Tubiana-Hulin M ct al	2004	Br J Cancer2004，91，8：	1
12	Anastrozole is superior to tamoxifen as first-line in hormone receptor positive advanced breast cancer显示文摘	BUZDAR A NABHOLTZ	2001	Cancer2001，92，：	1
13	Time dependency in plasmatic protein binding of cisplatin 显示文摘	Hecquet B Meynadier J Bonneterre J	1985	Cancer Treat Rep1985，69，1：	1
14	ERBB2 oncogenes in human breast cancer and its clinical significance显示文摘	Revillion F Bonneterre J Peyrat JP	1998	Eur J Cancer1998，34，6：	1
15	Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis,node-positive,early breast cancer:10-year follow-up results of the French Adjuvant Study Group 05 randomized trial显示文摘	Bonneterre J Roche H Kerbrat P	2005	J Clin Oncol2005，23，12：	1
16	Docetaxel vs 5 - fluorouracil pus vinorelbine in metastatic breast cancer after anthracycline therapy failure 显示文摘	Bonneterre J Roche H Monnier A	2002	Br J Cancer2002，87，11：	1
17	A medico-economic evaluation of second line chemotherapy in metastatic breast cancer:comparison between docetaxel,paclitaxel,and vinorelbine显示文摘	LAUNOIS RJ REBOUL-MARTY J M BONNETERRE J	1997	Bull Cancer1997，84，7：	1
18	A phase two randomised trial of neratinib monotherapy versus lapatinib plus capeeitabine combination therapy in patients with HER2+ advanced breast cancer显示文摘	Martin M Bonneterre J Geyer CE Jr	2013	Eur J Cancer2013，49，18：	1
19	Anastrozole is superiorto tamoxifen as first-line in hormone receptor positive advanced breastcancer显示文摘	Bonneterre J Buzdar A Nabholtz J M	2001	Cancer2001，92，：	1
20	Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer显示文摘	Decouvelaere C Peyrat JP Bonneterre J	1995	Cell Growth Differ1995，6，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示